Latest Routes of administration Stories

NORWOOD, Mass., Nov. 1, 2012 /PRNewswire-USNewswire/ -- The Infusion Nurses Society has enhanced and revised its Policies and Procedures for Infusion Nursing of the Older Adult and will make it available for purchase November 15. The original version of the publication was developed through a grant from the Nurse Competence in Aging Initiative supported by the John A. Hartford Foundation's Institute for Geriatric Nursing. Written in a user-friendly format and spiral-bound for ease...

MIAMI LAKES, Fla., Oct. 23, 2012 /PRNewswire/ -- Fuse Science, Inc. (OTCQB: DROP) (www.fusescience.com), an innovative company that possesses proprietary delivery technology set to redefine how consumers receive energy, medicines, vitamins and minerals, today provides further insight into the numerous potential applications of their technology arising from their most recent scientific testing research results. The conclusions of the research documented that the Company can deliver a...

YARDLEY, Pa., Oct. 18, 2012 /PRNewswire/ -- OptiNose US Inc., today announced the publication of results from a study which showed that the proportion of the dose delivered to the blood vessel-rich middle and upper posterior regions in the back of the nose is three times higher with the OptiNose breath-powered Bi-Directional(TM) nasal delivery device than traditional liquid nasal spray. The study "Nasal Deposition and Clearance in Man: Comparison of a Bi-directional Powder Device...

YARDLEY, Pa., Oct. 2, 2012 /PRNewswire/ -- OptiNose US Inc. today announced results of a study testing delivery of the migraine medicine sumatriptan with a novel device using OptiNose breath powered Bi-Directional(TM) nasal technology. In a direct comparison of drug absorption, the study found that OptiNose's sumatriptan product sent 62% more drug into the blood in the critical first 15 minutes than Imitrex(®) nasal spray (AUC (0-15) = 1.69 ng*hr/mL and 1.04 ng*hr/mL,...

BROOMALL, Pa., Feb. 15, 2012 /PRNewswire/ -- Transdermal Specialties, Inc (TSI) is a pioneer in Ultrasonic active patch delivery systems for the Drug and Skincare industries. The Company has completed clinical trials of its U-Wand(TM) Anti-Acne System. The U-Wand(TM) is an ultrasonic product applicator device with the ability to generate ultrasonic transmissions of variable intensity and frequency on a programmed schedule that dilates the skin's pores to allow easy acceptance of...

FRANKLIN, Mass., March 1, 2011 /PRNewswire/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing the Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery, today announced that it won the prestigious 2011 North American Frost & Sullivan Technology Innovation Award in Pharmaceuticals and Biotechnology. Echo received this award in recognition of...

JERUSALEM, November 22, 2010 /PRNewswire-FirstCall/ -- Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that that the company's board of directors has approved the research and development of two new medical locking device products. In addition to the company's patented syringe locking device, the company will now seek to develop bar-coded locking...

SOUTHAMPTON, Mass., Sept. 21 /PRNewswire/ -- Product innovators Chris and Sonia Hillios are pleased to announce that they have been granted a patent by the U.S. Patent and Trademark Office pertaining to their new syringe injection system, ConfiDisc(R). The patent covers the innovator's syringe injection system, which enables users to achieve the correct angle and depth of subcutaneous and intramuscular injections. The ConfiDisc(R) Syringe Injection System was developed for insulin and like...

FRANKLIN, Mass., May 21 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude(TM) SkinPrep System for transdermal drug delivery, announced today that the Chairman of its Scientific Advisory Board, Dr. Robert Langer, a world-renowned engineer at Massachusetts Institute of Technology (MIT) discussed his...

PISCATAWAY, N.J., May 3 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that the United States Patent and Trademark Office has issued a Notice of Allowance for Milestone's U.S. patent application, titled "Self-Administration Injection System." Milestone's innovative computer-controlled drug delivery platform has been designed to reduce the anxiety and pain of self-administration of...